| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 132 |
| 1 | METHOTREXATE | 119 |
| 2 | CYCLOPHOSPHAMIDE | 107 |
| 3 | CYCLOPHOSPHAMIDE FOR INJECTION | 107 |
| 4 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 107 |
| 5 | TIGECYCLINE | 99 |
| 6 | CYTARABINE | 97 |
| 7 | DEXAMETHASONE | 93 |
| 8 | DEXAMETHASONE 1.5 MG | 93 |
| 9 | PEGASPARGASE | 93 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TAFENOQUINE SUCCINATE | 2 | 0.1818 |
| 1 | ERAVACYCLINE | 29 | 0.0973 |
| 2 | TIGECYCLINE | 99 | 0.0159 |
| 3 | THROMBIN TOPICAL RECOMBINANT | 1 | 0.0147 |
| 4 | OBECABTAGENE AUTOLEUCEL | 1 | 0.0141 |
| 5 | DAUNORUBICIN HYDROCHLORIDE | 20 | 0.0121 |
| 6 | VALERIAN ROOT, PASSIFLORA, MAGNESIUM CARBONATE | 2 | 0.0108 |
| 7 | PEGASPARGASE | 93 | 0.0075 |
| 8 | ERYTHROMYCIN LACTOBIONATE | 1 | 0.0068 |
| 9 | SILTUXIMAB | 4 | 0.0062 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 233 |
| 1 | Folate Analog Metabolic Inhibitor [EPC] | 119 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 118 |
| 3 | Alkylating Drug [EPC] | 113 |
| 4 | Osmotic Laxative [EPC] | 106 |
| 5 | Tetracycline-class Antibacterial [EPC] | 104 |
| 6 | Asparagine-specific Enzyme [EPC] | 93 |
| 7 | Interleukin-6 Receptor Antagonist [EPC] | 64 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 64 |
| 9 | Loop Diuretic [EPC] | 40 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Tetracycline-class Antibacterial [EPC] | 104 | 0.0132 |
| 1 | Asparagine-specific Enzyme [EPC] | 93 | 0.0069 |
| 2 | Interleukin-6 Antagonist [EPC] | 4 | 0.0062 |
| 3 | Vasoconstrictor [EPC] | 1 | 0.0033 |
| 4 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 3 | 0.0028 |
| 5 | CD19-directed Chimeric Antigen Receptor [EPC] | 24 | 0.0024 |
| 6 | CD123 Interaction [EPC] | 1 | 0.0019 |
| 7 | CD22-directed Immunoconjugate [EPC] | 5 | 0.0017 |
| 8 | Lymphocyte Growth Factor [EPC] | 2 | 0.0016 |
| 9 | Serotonin-4 Receptor Agonist [EPC] | 1 | 0.0015 |